MEDP General Counsel sold 16,349 shares at $450.00 on 2026-05-28, reducing holdings 44.6% to 20,343 shares; stock now -28.2% from 52-week high.
Stephen P Ewald, General Counsel & Corp. Secy., sold 16,349 shares (16.3K shares) of Medpace Holdings at $450.00, generating $7,357,050.00 ($7.4M) and reducing his non-derivative holdings by 44.6% from 36,692 shares to 20,343 shares. The stock has declined 28.2% from its 52-week high of $628.92 and is currently trading at $451.47, near the transaction price. Ewald's cross-ticker history shows 5 prior sells against only 1 buy across all holdings. The company itself remains fundamentally solid with $706.6M in quarterly revenue, $123.9M net income, and 20.0% annual revenue growth, trading at a P/E of 28.01 with a $12.9B market cap, suggesting the sale reflects a portfolio decision rather than distress. Investors should note the substantial share reduction by a senior officer concurrent with a significant retreat from the stock's recent highs.